Biotalys NV Statistics
Total Valuation
Biotalys NV has a market cap or net worth of EUR 123.65 million. The enterprise value is 105.86 million.
Market Cap | 123.65M |
Enterprise Value | 105.86M |
Important Dates
The last earnings date was Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biotalys NV has 37.47 million shares outstanding. The number of shares has increased by 5.28% in one year.
Current Share Class | n/a |
Shares Outstanding | 37.47M |
Shares Change (YoY) | +5.28% |
Shares Change (QoQ) | +6.86% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 5.39% |
Float | 12.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 4.48 |
P/TBV Ratio | 4.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.03 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -8.29 |
Financial Position
The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.18.
Current Ratio | 5.50 |
Quick Ratio | 4.95 |
Debt / Equity | 0.18 |
Debt / EBITDA | n/a |
Debt / FCF | -0.38 |
Interest Coverage | -85.94 |
Financial Efficiency
Return on equity (ROE) is -49.60% and return on invested capital (ROIC) is -26.31%.
Return on Equity (ROE) | -49.60% |
Return on Assets (ROA) | -23.00% |
Return on Invested Capital (ROIC) | -26.31% |
Return on Capital Employed (ROCE) | -42.19% |
Revenue Per Employee | n/a |
Profits Per Employee | -209,333 |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.14% in the last 52 weeks. The beta is 0.91, so Biotalys NV's price volatility has been similar to the market average.
Beta (5Y) | 0.91 |
52-Week Price Change | +7.14% |
50-Day Moving Average | 3.36 |
200-Day Moving Average | 3.12 |
Relative Strength Index (RSI) | 44.09 |
Average Volume (20 Days) | 24,258 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -13.49M |
Pretax Income | -13.15M |
Net Income | -13.19M |
EBITDA | -12.35M |
EBIT | -13.49M |
Earnings Per Share (EPS) | -0.40 |
Balance Sheet
The company has 22.64 million in cash and 4.85 million in debt, giving a net cash position of 17.79 million or 0.47 per share.
Cash & Cash Equivalents | 22.64M |
Total Debt | 4.85M |
Net Cash | 17.79M |
Net Cash Per Share | 0.47 |
Equity (Book Value) | 27.61M |
Book Value Per Share | 0.74 |
Working Capital | 21.47M |
Cash Flow
In the last 12 months, operating cash flow was -12.65 million and capital expenditures -115,000, giving a free cash flow of -12.77 million.
Operating Cash Flow | -12.65M |
Capital Expenditures | -115,000 |
Free Cash Flow | -12.77M |
FCF Per Share | -0.34 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biotalys NV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.28% |
Shareholder Yield | -5.28% |
Earnings Yield | -10.67% |
FCF Yield | -10.32% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |